Back to the main directory
EarningsReview / Equity
- Further slight capex adjustment but mid- to long-term story unchanged by BNP Paribas Exane
- Asset value growth back on track by BNP Paribas Exane
- In the Flow by BNP Paribas Exane
- Still delivering on ambitious investment plan by BNP Paribas Exane
- Bulk annuity bonanza on the horizon by BNP Paribas Exane
- Bakkafrost (Sell, TP: NOK430.00) - DKK3bn of capex in focus by DnB Markets
- Hufvudstaden (Sell, TP: SEK133.00) - Rich valuation and debt risk; SELL by DnB Markets
- Alimak (Buy, TP: SEK170.00) - Why we like Q2 despite the miss by DnB Markets
- 360 Report | Valora | Reduce | SBB derailment risk by Kepler Cheuvreux
- GN Group (Sell, TP: DKK250.00) - Another GN Audio upgrade by DnB Markets
- Under Control by BNP Paribas Exane
- Marine Harvest (Hold, TP: NOK185.00) - Large cuts in volume guidance in focus, softened by increased debt target and positive demand outlook by DnB Markets
- Investment Daily 22/08/2018 by BNP Paribas Exane
- Q218 results and 15 questions for management by BNP Paribas Exane
- Norwegian bank survey 2018 - Set to benefit from higher activity by DnB Markets
- Best of: New Luxury by BNP Paribas Exane
- Espresso | B&S Group | Buy | H1 update after months of silence by Kepler Cheuvreux
- SalMar (Sell, TP: NOK320.00) - EBIT miss on high contract share by DnB Markets
- Prosafe (Hold, TP: NOK20.00) - Q2 in line, 2019 consensus high by DnB Markets
- Tails up by BNP Paribas Exane
- Olav Thon (Buy, TP: NOK210.00) - Keeps on delivering by DnB Markets
- SalMar (Sell, TP: NOK320.00) - Marginally below expectations by DnB Markets
- BioArctic (Buy, TP: SEK206.00) - Waiting for more data on BAN2401 by DnB Markets
- Approaching a turn in the rate cycle by BNP Paribas Exane
- Höegh LNG Holdings (Buy, TP: NOK63.00) - Increased tender activity by DnB Markets
- Investment Daily 17/08/2018 by BNP Paribas Exane
- Pacific Drilling (No_rec, TP: USD) - Solution in place by DnB Markets
- Bakkafrost (Sell, TP: NOK430.00) - Higher than expected one-off-driven EBIT, new capex plan will strain free cash flow in the years ahead by DnB Markets
- Investment Daily 21/08/2018 by BNP Paribas Exane
- Elekta (Buy, TP: SEK140.00) - Unity orders important by DnB Markets
- Isofol MedicalWaiting for initiation of phase III by DnB Markets
- Ambea (Hold, TP: SEK81.00) - by DnB Markets
- Latour (Buy, TP: SEK115.00) - In shape to outperform by DnB Markets
- Grieg Seafood (Buy, TP: NOK115.00) - Headline beat, but cut to volume guidance due to PD in Rogaland by DnB Markets
- Ambea (Hold, TP: SEK81.00) - by DnB Markets
- Strengthening the ecosystem by BNP Paribas Exane
- Lerøy Seafood (Hold, TP: NOK65.00) - Big miss for Sjøtroll means we see 5–8% cut in consensus EPS by DnB Markets
- BerGenBio (Buy, TP: NOK56.00) - Focus on NSCLC by DnB Markets
- GN Group (Sell, TP: DKK270.00) - by DnB Markets
- Private Equity has insurance in its sights by BNP Paribas Exane
- A warning for all by BNP Paribas Exane
- Frontline (Buy, TP: NOK60.00) - On track to meet our 2019 forecasts by DnB Markets
- Nordic Nanovector (Buy, TP: NOK110.00) - PARADIGME on track by DnB Markets
- Investment Daily 23/08/2018 by BNP Paribas Exane
- Ambu (Buy, TP: DKK310.00) - Q3 and new guidance miss by DnB Markets
- Grieg Seafood (Buy, TP: NOK115.00) - Non-Norway to the rescue by DnB Markets
- H118 postview (+15 questions for management) by BNP Paribas Exane
- Solon Eiendom (Buy, TP: NOK33.00) - EPS Ski lift by DnB Markets
- Dark clouds on the horizon? by BNP Paribas Exane
- Golar LNG (Buy, TP: USD39.00) - Poised for a breakthrough by DnB Markets